Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

23,580 signal articles · 325 in last 24h · 112,379 total before filter · latest 1h ago

325last 24h

2136last 7d

376● bullish (7d)

188● bearish (7d)

204publishers

All Macro294 Earnings1215 M&A91 Regulatory23 Product13 Analyst20

✕ clear all filtersticker: GILDSentiment:bullish neutral bearish show all (incl. clickbait)

Insider Monkey46d agobullish

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

GILD MRK ^GSPC

Stocktwits82d agobullish

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment

U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus.

GILD